Researchers at Ludwig Cancer Research Oxford have used functional genomics to suppress the function of H3K27M mutant histones, which are responsible for driving 80% of incurable childhood brain tumours. Their results have revealed a previously unstudied way to develop a potential new treatment for childhood cancer. Read more 👉 https://lnkd.in/evuqPPx7
Nuffield Department of Medicine’s Post
More Relevant Posts
-
🚀 Exciting Developments in Cancer Research: The Power of Resveratrol 🚀 I recently delved into the fascinating article, "Resveratrol's Anti-Cancer Effects through the Modulation of Tumor Metabolism"
To view or add a comment, sign in
-
✴️ Shining a Light on Northeastern Ontario Cancer Research! Northeastern Ontario researchers are making strides in the fight against cancer! Dr. Amadeo Parissenti (https://lnkd.in/e3RPcrmR) Dr. Parissenti's research focuses on how chemotherapy agents induce changes in tumour cells (such as RNA degradation) and how responses can be used to predict patient outcomes and tailor patient care. Take a look at Dr. Amadeo Parissenti's research publications on ResearchGate. https://lnkd.in/eDYTJrhJ
To view or add a comment, sign in
-
-
𝗧𝗿𝗮𝗰𝗸𝗶𝗻𝗴 𝗗𝗼𝘄𝗻 𝘁𝗵𝗲 𝗚𝗲𝗻𝗲𝘁𝗶𝗰𝘀 𝗼𝗳 𝗧𝘂𝗺𝗼𝗿𝘀 🎙️#Interview with PI Prof. Markus Diefenbacher: Get to Know our Expert for Lung Cancer at the Institute of Lung Health and Immunity. With his team, Prof. Markus Diefenbacher aims to decipher the genetic complexity of tumors and to develop innovative therapies against lung cancer. 👉 Check out his interview: https://lnkd.in/dPCUeQZP #interview #research #lung #health #cancer #tumor #ImmuneSystem #LungCancer
To view or add a comment, sign in
-
I love this study, such an intriguing finding on the biology of cancer recurrence, and with key implications for the treatment of Glioblastoma. It also shows the power of combining single cell with spacial biology in order to reveal this important recurrence mechanism. Congratulation to the authors!
Congratulations to Watson, Zomer, Joyce, and colleagues for their latest paper being featured on the cover of Cancer Cell! Read the synopsis in our press release and see how researchers in the lab of Professor Johanna Joyce (University of Lausanne) and the Ludwig Institute for Cancer Research united Xenium #spatialbiology with Chromium #singlecell to uncover mechanisms of #glioblastoma resistance: https://bit.ly/3ZjA2gk
To view or add a comment, sign in
-
Discover the insights from our latest scientific blog: "The Vital Role of Highly Characterized Glioblastoma PDX Models in Preclinical Cancer Research." During brain cancer awareness month, explore how TD2's study showcases over 100 GBM PDX models, and download the poster to understand the significant potential of these models in bridging the gap between lab discoveries and clinical breakthroughs. https://hubs.li/Q02wKKRk0 #TD2 #CancerResearch #GBM #PDXModels #AACR2024
To view or add a comment, sign in
-
-
For all those working through the GBM gauntlet. If there's anything that you think Translational Drug Development (TD2) may be able to help with, please DM me. #GBM #CancerResearch #GBM #PDXModels #Preclinical #DrugDevelopment
Discover the insights from our latest scientific blog: "The Vital Role of Highly Characterized Glioblastoma PDX Models in Preclinical Cancer Research." During brain cancer awareness month, explore how TD2's study showcases over 100 GBM PDX models, and download the poster to understand the significant potential of these models in bridging the gap between lab discoveries and clinical breakthroughs. https://hubs.li/Q02wKKRk0 #TD2 #CancerResearch #GBM #PDXModels #AACR2024
To view or add a comment, sign in
-
-
🌟 Thrilled to share our latest publication! 🌟 This week, our work was published in Receptors MDPI: “Molecular Perspectives on Prostate Cancer: The Role of microRNAs in Androgen Receptor Regulation”. In this review, we explore the critical role of microRNAs in androgen receptor regulation—a key player in prostate cancer biology. A huge thanks to the amazing team behind this project. Asbiel Felipe Garibaldi Rios.Let’s keep pushing the boundaries of cancer research! 📖 Read more here: https://lnkd.in/eaW5SCYe #Research #Science #ProstateCancer #microRNAs #ReceptorsMDPI
To view or add a comment, sign in
-
“Studying the moment where and when a relatively passive tumor cell acquires the ability to move and metastasize could be a game changer for cancer treatment,” says Carlos Carmona-Fontaine, an associate professor of biology at NYU. That's why researchers have created a 3D-printed model to study the process previously hidden from view, a step towards figuring out why and how these cancer cells migrate. Read more: http://spr.ly/6040xyVME 📹 : Video by David Song
NYU Researchers Develop Tiny Tumor Model That Recreates Cancer Metastasis
To view or add a comment, sign in
-
📝We share with you the #Review "Nerve Density and Neuronal Biomarkers in Cancer" 👥by Shahrukh R. Ali et al. The University of Texas Medical Branch Find the full paper here⏭️ https://lnkd.in/dPEs4a65 Keywords: neoplasms; cancer; tumor microenvironment
To view or add a comment, sign in
-
-
Epigenetic pathways and combinations are opening promising positive impacts to hard to treat cancer patients. So interesting
Our 6th Biennial Miami Epigenetics and Cancer Symposium, held Nov. 16 and 17 attracted epigenetics experts from top cancer centers and institutions to discuss the latest in histone modifications, chromatin/transcription deregulation and epigenetics and metabolism in cancer. Sessions focused on elucidating the epigenetic pathways in cancer cells that could be targeted therapeutically to inhibit tumor growth and resistance, as well as metabolism and the role of aging in cancer. Thank you to our organizers, Drs. Stephen Nimer and Ramin Shiekhattar. Huge thanks to everyone who attended—we look forward to seeing you in 2026! #TeamScience
To view or add a comment, sign in